Validation of a Drug-Related Problem Classification System for the Intermediate and Long-Term Care Setting in Singapore

Xin Yan Lim, Quan Qi Yeo, Grace Li Lin Kng, Wing Lam Chung, Kai Zhen Yap, Xin Yan Lim, Quan Qi Yeo, Grace Li Lin Kng, Wing Lam Chung, Kai Zhen Yap

Abstract

Background: This study aims to evaluate the inter-rater reliability and perceived usability of a newly developed drug-related problem (DRP) classification system for use by pharmacists in the intermediate and long-term care (ILTC) setting in Singapore.

Methods: This was a cross-sectional survey study involving the use of a self-administered questionnaire. All 55 pharmacists affiliated to the Pharmaceutical Society of Singapore (PSS) ILTC Pharmacists Workgroup who were above 21 years old and not authors of the classification system were invited to participate. The inter-rater reliability of participants' classification of 46 mock DRP cases using the new DRP classification system was determined using Fleiss's kappa (κ). Participants' perceived usability of the classification system was evaluated using six items with five-point Likert scales (1-"strongly disagree", 5-"strongly agree"). Results: Thirty-three pharmacists responded to the survey. Overall inter-rater reliability was found to be substantial (κ = 0.614; 95% CI: 0.611⁻0.617). All usability items received positive ratings ("strongly agree" or "agree") from at least 69% of participants. Conclusion: The new DRP classification system has substantial external validity and appears to be suitable for use by pharmacists to document and report DRPs in the ILTC setting in Singapore and facilitate evaluation of the impact of pharmaceutical care in the ILTC setting.

Keywords: classification system; drug-related problem; intermediate and long-term care; nursing home; validation.

Conflict of interest statement

All authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Kappa values for participants of various practice experiences (with 95% CI; * denotes significant difference).

References

    1. Pharmaceutical Care Network Europe Pharmaceutical Care Network Europe Classification for Drug Related Problems V7. [(accessed on 20 August 2018)]; Available online: .
    1. Ernst F.R., Grizzle A.J. Drug-related morbidity and mortality: Updating the cost-of-illness model. J. Am. Pharm. Assoc. 2001;41:192–199. doi: 10.1016/S1086-5802(16)31229-3.
    1. Cipolle R.J., Strand L., Morley P. Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management. 3rd ed. McGraw-Hill Education; New York, NY, USA: 2012. pp. 141–182.
    1. Van Mil J.W., Westerlund L.O., Hersberger K.E., Schaefer M.A. Drug-related problem classification systems. Ann. Pharmacother. 2004;38:859–867. doi: 10.1345/aph.1D182.
    1. Chia H.S., Ho J.A., Lim B.D. Pharmacist review and its impact on Singapore nursing homes. Singap. Med. J. 2015;56:493–501. doi: 10.11622/smedj.2015133.
    1. Hohmann C., Eickhoff C., Klotz J.M., Schulz M., Radziwill R. Development of a classification system for drug-related problems in the hospital setting (APS-Doc) and assessment of the inter-rater reliability. J. Clin. Pharm. Ther. 2012;37:276–281. doi: 10.1111/j.1365-2710.2011.01281.x.
    1. Williams M., Peterson G.M., Tenni P.C., Bindoff I.K., Stafford A.C. Document: A system for classifying drug-related problems in community pharmacy. Int. J. Clin. Pharm. 2012;34:43–52. doi: 10.1007/s11096-011-9583-1.
    1. Silva C., Ramalho C., Luz I., Monteiro J., Fresco P. Drug-related problems in institutionalized, polymedicated elderly patients: Opportunities for pharmacist intervention. Int. J. Clin. Pharm. 2015;37:327–334. doi: 10.1007/s11096-014-0063-2.
    1. Basger B.J., Moles R.J., Chen T.F. Application of drug-related problem (DRP) classification systems: A review of the literature. Eur. J. Clin. Pharmacol. 2014;70:799–815. doi: 10.1007/s00228-014-1686-x.
    1. Hepler C.D., Strand L.M. Opportunities and responsibilities in pharmaceutical care. Am. J. Hosp. Pharm. 1990;47:533–543.
    1. Ministry of Social and Family Development Committee on Ageing Issues: Report on the Ageing Population 2006. [(accessed on 25 August 2018)]; Available online: .
    1. Pharmaceutical Society of Singapore PSS ILTC Pharmacist Workgroup Inaugural Management Meeting. [(accessed on 11 January 2016)]; Available online: .
    1. Basger B.J., Moles R.J., Chen T.F. Development of an aggregated system for classifying causes of drug-related problems. Ann. Pharmacother. 2015;49:405–418. doi: 10.1177/1060028014568008.
    1. AbuRuz S.M., Bulatova N.R., Yousef A.M. Validation of a comprehensive classification tool for treatment-related problems. Pharm. World Sci. 2006;28:222–232. doi: 10.1007/s11096-006-9048-0.
    1. Eichenberger P.M., Lampert M.L., Kahmann I.V., van Mil J.F., Hersberger K.E. Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm. World Sci. 2010;32:362–372. doi: 10.1007/s11096-010-9377-x.
    1. Maes K.A., Tremp R.M., Hersberger K.E., Lampert M.L. Demonstrating the clinical pharmacist’s activity: Validation of an intervention oriented classification system. Int. J. Clin. Pharm. 2015;37:1162–1171. doi: 10.1007/s11096-015-0179-z.
    1. Fleiss J.L. Measuring nominal scale agreement among many raters. Psychol. Bull. 1971;76:378–382. doi: 10.1037/h0031619.
    1. IBM Stats Fleiss Kappa. [(accessed on 19 December 2016)]; Available online: .
    1. Landis J.R., Koch G.G. The Measurement of Observer Agreement for Categorical Data. Biometrics. 1977;33:159–174. doi: 10.2307/2529310.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren